Units Plummets After Novo Nordisk Deal Breakdown
Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending its stock price plummeting by nearly 10%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it could b